Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 227 - -
Change - -8.16% -23.89% -11.68% 52.89% 29.19% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 227 227 227
Change - -8.16% -23.89% -11.68% 52.89% 29.19% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.8x 0.71x 0.63x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.29x 0.28x 0.28x
EV / Revenue 0x 0x 0x 0x 0x 0.29x 0.28x 0.28x
EV / EBITDA 0x 0x 0x 0x 0x 1.99x 1.97x 1.96x
EV / EBIT 0x 0x 0x 0x 0x 3.66x 3.63x 3.62x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.84% 0.84% 0.84%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 4.780 4.780 4.780
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 3/30/22 3/31/23 3/27/24 3/28/25 3/27/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - 0.84% 263M
31.63x3.01x13.49x1.37% 17.73B
51.96x4.44x28.96x0.27% 13.41B
19.4x2.3x10.73x0.64% 12.19B
22.35x3.14x11.2x1.92% 11.97B
25.73x2.07x16.72x0.15% 10.5B
85.17x7.4x28.64x - 9.72B
19.15x2.79x11.51x4.17% 9.36B
53.77x6.79x29.36x0.14% 7.33B
34.21x0.94x7.83x1.89% 7.31B
Average 38.15x 3.65x 17.61x 1.27% 9.98B
Weighted average by Cap. 37.01x 3.57x 17.35x 1.27%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MED Stock
  4. Valuation MEDICLIN AG